pharma · Monocarboxylate Transporter 8 (MCT8) deficiency
Rare Thyroid Therapeutics
Rare Thyroid Therapeutics International AB
Rare Thyroid Therapeutics clinical programs — 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Stockholm, SE HQ
2017 Founded
1 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- Stockholm, SE
- Founded
- 2017
- Employees
- 1
- Programs
- 2
- Drugs
- 6
- Patents
- 0
Rare Thyroid Therapeutics projects
1 ClinicalTrials.gov programs sponsored by Rare Thyroid Therapeutics.
Rare Thyroid Therapeutics has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
Frequently asked questions
How many clinical projects does Rare Thyroid Therapeutics have?
1 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.